This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Tuesday's ETF Winners & Losers

Health care-related exchange-traded funds were among the top performers of Tuesday's session, thanks to an upswing in several biotech and medical device manufacturer stocks.

The Biotech HOLDRs (BBH) was higher by 1.1%. Among its holdings, Genentech (DNA) was rising 2.3%, Amgen (AMGN) gained 1.4%, and Gilead Sciences (GILD) tacked on 1%.

Recently, the Biotech HOLDRs was higher by $2.12 to $189.27.

The iShares Dow Jones U.S. Medical Devices (IHI) was also higher, thanks to gains of 2% or more in holdings St. Jude Medical (STJ), Boston Scientific (BSX) and Medtronic (MDT).

The ETF was gaining 41 cents, or 0.8%, to $54.87.

On the losing side, the Internet Infrastructure HOLDRs (IIH) slid more than 2%. Among its holdings, BEA Systems (BEAS) was slumping 3.8%, Akamai Technologies (AKAM) was losing 2.6%, and VeriSign (VRSN) was down 1.9%.

The Internet Infrastructure HOLDRs ETF was recently falling 11 cents, or 2.2%, to $4.97.

Other Internet names were suffering. Ariba (ARBA) fell 2.3%, and Checkfree (CKFR) was shedding 0.5%. Both holdings combined to sink the B2B Internet HOLDRs (BHH), which was recently down 3 cents, or 1.5%, to $2.

ETFs tracking silver and gold were also lower. Silver futures dropped 20 cents to $13.37 an ounce. Gold futures lost $6.20 to close at $677.30 an ounce

The iShares Silver Trust (SLV) was shedding 1.4% to $131.45. The Market Vectors Gold Miners (GDX) eased 1.2% to $39.09. The PowerShares DB Silver (DBS) ETF was recently down 1.2% to $26.09. The streetTRACKS Gold Shares (GLD) ETF was off 0.6% to $66.71.

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
BBH $109.03 -0.13%
DBS $27.75 0.00%
GDX $24.66 1.60%
IHI $129.56 0.00%
SLV $16.87 0.60%


Chart of I:DJI
DOW 17,830.76 -210.79 -1.17%
S&P 500 2,075.81 -19.34 -0.92%
NASDAQ 4,805.2910 -57.85 -1.19%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs